Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.

Landen Shane BurstinerAnna H OwingsAmor RoyerYousef HreishJeshanah JohnsonMadelyn BarrHannah LairdSpurthi TaruguKane EdwardsLauren BradleyHimmat BrarTanya O RobinsonPegah Hosseini-CarrollJulia LiuSarah Camille Glover

Published in: Inflammatory bowel diseases (2023)

Black IBD patients on anti-TNF agents had a significantly higher prevalence of active disease and more IBD-related hospitalizations than White patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported